USPatent applicationPatented

Phenylamidines having a high fungicidal activity and use thereof

Granted 26 May 2015 · 1 office action

Life of the application

9 dated events
⤢ drag to zoom20122014201620182020202220242026202820302032ProsecutionOwnershipTerm & fees
ProsecutionOwnershipTerm & feeshover for detail · click to open

Abstract

New phenylamidines are described, having general formula (I): [structure] and their use for the control of phytopathogenic fungi.

Description

13 parts
›The present invention relates to phenylamidines having a…

The present invention relates to phenylamidines having a high fungicidal activity and their relative use, in particular substituted phenylamidines having a high fungicidal activity and their use for the control of phytopathogenic fungi of important agricultural crops.

Phenylamidines having a high fungicidal activity are described in international patent applications WO 2000/46184, WO 2003/093224, WO 2007/031508, WO 2007/031512, WO 2007/031513, WO 2007/031523, WO 2007/031524, WO 2008/110279.

The products described in these documents, however, are often unsatisfactory from the point of view of both the level of activity with respect to phytopathogenic fungi and also, or alternatively, from the point of view of phytotoxicity with respect to important agricultural crops.

In particular, for example, the compounds N-ethyl-N-methyl-N′-[4-(3-trifluoromethylphenoxy)-2,5-xilyl]-formamidine, N,N-dimethyl-N′-[4-(3-trifluoromethylphenoxy)-2,5-xilyl]formamidine, N,N-dimethyl-N′-[4-(3-trifluoromethoxyphenoxy)-2,5-xilyl]formamidine, N,N-dimethyl-N′-[4-(3-trifluoroethoxyphenoxy)-2,5-xilyl]-formamidine, described in international patent application WO 00/46184, at the doses which allow a good fungicidal activity to be obtained, show a marked leaf necrosis on cereals, cucumbers, tomatoes and other important crops: this effect makes their use as fungicides practically unacceptable. On the other hand, the compound N,N-dimethyl-N′-[4-(3-trifluoromethylphenylthio)-2,5-xilyl]formamidine, also described in international patent application WO 00/46184, proves to be insufficient from the point of view of fungicidal activity, which is only exerted satisfactorily in excessively high dosages.

International patent application WO 2008/110278 describes a whole series of (hetero)aryloxy- and (hetero)arylthio N,N-dialkyl-N′-phenyl-formamidines with a herbicidal activity, variously substituted on the (hetero)aryloxy and (hetero)arylthio rings.

The Applicant has now surprisingly found that new phenylamidines characterized by a (hetero)arylthio group in position 4 of the phenyl, and by particular combinations of substituents on the (hetero)arylthio ring and on the nitrogen atom, not only exert an excellent fungicidal activity at low doses, but are also well tolerated by many vegetable species, thus allowing the practical use of these compounds for the control of phytopathogenic microorganisms of important agricultural crops.

An object of the present invention therefore relates to new phenylamidines having general formula (I):

wherein

R represents a phenyl, pyridyl, pyrimidyl, pyrazyl or pyridazyl group, all groups substituted by at least a substituent selected from C 1 -C 6 polyfluoroalkoxy containing at least one hydrogen atom, C 1 -C 6 polyfluoroalkylthio containing at least one hydrogen atom, C 3 -C 6 cycloalkyl, C 3 -C 6 halocycloalkyl, C 3 -C 6 cycloalkoxy, C 3 -C 6 halocycloalkoxy, C 4 -C 8 cycloalkylalkoxy, C 4 -C 8 halocycloalkylalkoxy; said groups phenyl, pyridyl, pyrimidyl, pyrazyl or pyridazyl being optionally substituted by one or two further substituents, equal to or different from each other, selected from halogen atom, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl;

R 1 represents C 2 -C 6 alkyl;

R 2 represents C 1 -C 6 alkyl; or R 1 and R 2 , together with the N atom to which they are bound, form a heterocyclic ring containing from 4 to 7 atoms, optionally substituted by halogen atoms;

R 3 and R 4 , equal to or different from each other, represent a hydrogen atom, a halogen atom, a C 1 -C 6 alkyl, a C 1 -C 6 alkoxy, a C 1 -C 6 haloalkoxy, a CF 3 group, a CF 2 H group, a CFH 2 group, a cyano group.

Examples of halogen are fluorine, chlorine, bromine, iodine.

Examples of C 1 -C 6 alkyl are methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tertbutyl, n-pentyl, 3-methylbutyl, n-hexyl, 3,3-dimethylbutyl.

Examples of C 1 -C 6 haloalkyl are fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloro-methyl, 2,2,2-trifluoroethyl, 1,1,2,2-tetrafluoroethyl, pentafluoroethyl, heptafluoropropyl, 4,4,4-trichloro-butyl, 4,4-difluoropentyl, 5,5-difluorohexyl.

Examples of C 1 -C 6 polyfluoroalkoxy group containing at least one hydrogen atom are difluoromethoxy, 2,2,2-trifluoroethoxy, 1,1,2,2-tetrafluoroethoxy, 2,2,3,3-tetrafluoropropoxy, 2,2,3,3,3-pentafluoropropoxy, 1,1,2,3,3,3-hexafluoropropoxy, 2,2,3,4,4,4-hexafluorobutoxy, 4,4-difluoropentoxy, 4,4,5,5,5-pentafluoropentoxy, 2,2,3,3,4,4,5,5-octafluoropentoxy, 5,5-difluorohexyloxy.

Examples of C 1 -C 6 polyfluoroalkylthio group containing at least one hydrogen atom are difluoromethylthio, 2,2,2-trifluoroethylthio, 1,1,2,2-tetrafluoroethylthio, 2,2,3,3-tetrafluoropropylthio, 2,2,3,3,3-pentafluoropropylthio, 1,1,2,3,3,3-hexafluoropropylthio, 2,2,3,4,4,4-hexafluorobutylthio, 4,4-difluoropentylthio, 4,4,5,5,5-pentafluoropentylthio, 2,2,3,3,-4,4,5,5-octafluoropentylthio, 5,5-difluorohexylthio.

Examples of C 3 -C 6 cycloalkyl are cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl.

Examples of a C 3 -C 6 halocycloalkyl are 2,2-dichlorocyclopropyl, 2,2-difluorocyclopropyl, 2,2,3,3-tetrafluorocyclobutyl, 3,3-difluorocyclopentyl, 2-fluorocyclohexyl.

Examples of C 3 -C 6 cycloalkoxy are cyclopropoxy, cyclobutoxy, cyclopentoxy, cyclohexyloxy.

Examples of C 3 -C 6 halocycloalkoxy are 2,2-dichlorocyclopropoxy, 2,2-difluorocyclopropoxy, 2,2,-3,3-tetrafluorocyclobutoxy, 3,3-difluorocyclopentoxy, 2-fluorocyclohexyloxy.

Examples of C 4 -C 8 cycloalkylalkoxy are cyclopropylmethoxy, cyclobutylmethoxy, cyclopentylmethoxy, cyclohexylmethoxy, cyclohexylethoxy.

Examples of C 4 -C 8 halocycloalkylalkoxy are 2,2-dichlorocyclopropylmethoxy, 2,2-difluorocyclopropylmethoxy, 2,2,3,3-tetrafluorocyclobutylmethoxy, 3,3-difluorocyclopentylmethoxy, 4,4-difluorocyclohexylmethoxy, 4,4-difluorocyclohexylethoxy.

Examples of heterocyclic rings with from 4 to 7 atoms optionally halogenated are: azetidine, 3,3-difluoroazetidine, pyrrolidine, piperidine, 4-fluoropiperidine, morpholine.

Representative examples of compounds having general formula (I) are those wherein R, R 1 , R 2 , R 3 and R 4 have the meanings indicated in Table 1.

›Preferred compounds of general formula (I) are those…

Preferred compounds of general formula (I) are those wherein:

R represents a phenyl, pyridyl, pyrimidyl, pyrazyl or pyridazyl group, all groups substituted by at least a substituent selected from difluoromethoxy, 2,2,2-trifluoroethoxy, 1,1,2,2-tetrafluoroethoxy, 2,2,3,3-tetrafluoropropoxy, 2,2,3,3,3-pentafluoropropoxy, 2,2,3,4,4,4-hexafluorobutoxy, 2,2,3,3,4,4,5,5-octafluoropentoxy, cyclopentoxy, cyclohexyloxy, cyclopropylmethoxy or cyclohexylmethoxy; said phenyl, pyridyl, pyrimidyl, pyrazyl or pyridazyl group being optionally substituted by one or two further substituents, equal to or different from each other, selected from a fluorine atom, a chlorine atom, methyl or trifluoromethyl;

R 1 represents ethyl, n-propyl, isopropyl;

R 2 represents methyl;

or R 1 and R 2 , together with the N atom to which they are bound, represent a pyrrolidyl, piperidyl or morpholyl group;

R 3 and R 4 represent methyl.

More preferred compounds of general formula (I) are those wherein:

R represents a phenyl group substituted by at least a substituent selected from difluoromethoxy, 2,2,2-trifluoroethoxy, 1,1,2,2-tetrafluoroethoxy, 2,2,3,3-tetrafluoropropoxy, 2,2,3,3,3-pentafluoropropoxy, 2,2,3,4,4,4-hexafluorobutoxy, 2,2,3,3,4,4,5,5-octa-fluoropentoxy, cyclopentoxy, cyclohexyloxy, cyclopropylmethoxy or cyclohexylmethoxy; said phenyl group being optionally substituted by one or two further substituents, equal to or different from each other, selected from a fluorine atom, a chorine atom, methyl or trifluoromethyl;

R 1 represents ethyl, n-propyl, isopropyl;

R 2 represents a methyl;

or R 1 and R 2 , together with the N atom to which they are bound, represent a pyrrolidyl, piperidyl or morpholylgroup;

R 3 and R 4 represent methyl.

The compounds having general formula (I) are prepared from the corresponding aniline having formula (II), according to the following reaction scheme 1:

Various methods for effecting this transformation are known in literature; the most widely used methods are the following:

a) treatment of aniline having formula (II) with an acetal having the formula R 1 R 2 NC(OR 5 ), wherein R 5 represents an alkyl, according to what is described in “Synthetic Communications”, 24 (1994), pages 1617-1624;

b) treatment of aniline having formula (II) with an amide having the formula HCONR 1 R 2 in the presence of POCl 3 or SOCl 2 , according to what is described in “Tetrahedron”, 46 (1990), pages 6058-6112;

c) treatment of aniline having formula (II) with an ortho-ester having the formula HC(OR 5 ), wherein R 5 represents an alkyl, to form the corresponding imino-ether followed by heating of the same in the presence of an amine having the formula HNR 1 R 2 , according to what is described in U.S. Pat. No. 4,209,319;

d) treatment of aniline having formula (II) with phosgene to form the corresponding isocyanate followed by reaction with an amide having the formula HCONR 1 R 2 , according to what is described in WO 00/46184;

e) treatment of aniline having formula (II) with C 2 H 5 OCH═NCN to form an N-cyanoamidine followed by reaction with an amine having the formula HNR 1 R 2 , according to what is described in WO 00/46184;

f) treatment of aniline having formula (II) with N,N-dimethylformamide in the presence of a sulfonyl-chloride, such as for example, 2-pyridylsulfonyl-chloride or phenylsulfonylchloride, to form the corresponding dimethylamidine (R 1 ═R 2 =Me) followed by reaction with an amine having the formula HNR 1 R 2 , according to what is described in “Tetrahedron”, 56 (2000), pages 8253-8262 and in “Journal Combinatorial Chemistry”, 11 (2009), pages 126-130.

The compound having formula (II) can be prepared by reduction of the corresponding nitro-derivative having formula (III), as indicated in reaction scheme 2, according to methods well-known in organic chemistry, as described for example in “Advanced Organic Chemistry”, Jerry March, 4 a Edition, 1992, John Wiley & Sons Pub., pages 1216-1217 and references cited therein.

The preferred reaction conditions for these substrates envisage the use of tin chloride in concentrated hydrochloric acid, according to what is described in detail in international patent application WO 00/46184.

The compound having formula (III) can be prepared by reaction of the compound having formula (IV) with a compound having formula RX, wherein X is a leaving group such as, for example, a halogen atom, a mesylate or a tosylate group, in the presence of a base, preferably potassium carbonate or sodium hydride, according to reaction scheme 3:

Alternatively, the compound having formula (III) can also be obtained by reaction of the compound having formula (V), wherein Y represents a halogen atom, with a compound having the formula RSH, in the presence of a base, preferably potassium carbonate or sodium hydride, according to reaction scheme 4.

The compounds having formula (IV) are prepared by reacting, in the presence of a palladium catalyst, a compound having formula (V) with potassium thioacetate and subsequently saponifying the thioester thus obtained, according to what is described in “Tetrahedron Letters”, 48 (2007), pages 3033-3037.

The compounds having general formula (I) containing polyfluoroalkoxy, (halo)cycloalkoxy or (halo)cycloalkylalkoxy groups on the ring R can also be obtained, by means of known techniques, starting from hydroxy-[(hetero)arylthio]phenylformamidines (obtainable as described in examples 4, 5 and 6) by addition to fluorinated olefins, as described in more detail in example 7, or by etherification with the corresponding halides or tosylates.

As already mentioned, the compounds having general formula (I) have an extremely high fungicidal activity which is exerted with respect to numerous phytopathogenic fungi which attack important agricultural crops.

Examples of phytopathogenic fungi which can be effectively treated and fought with the compounds having general formula (I) are those belonging to the groups of Basidiomycetes, Ascomycetes, Deuteromycetes or imperfect fungi, Oomycetes: Puccinia spp., Ustilago spp., Tilletia spp., Uromyces spp., Phakopsora spp., Rhizoctonia spp., Erysiphe spp., Sphaerotheca spp., Podosphaera spp., Uncinula spp., Helminthosporium spp., Rhynchosporium spp., Pyrenophora spp., Monilinia spp., Sclerotinia spp., Septoria spp. ( Mycosphaerella spp.), Venturia spp., Botrytis spp., Alternaria spp., Fusarium spp., Cercospora spp., Cercosporella herpotrichoides, Colletotrichum spp., Pyricularia oryzae, Sclerotium spp., Phytophtora spp., Pythium spp., Plasmopara viticola, Peronospora spp., Pseudoperonospora cubensis, Bremia lactucae.

›The main crops which can be protected with…

The main crops which can be protected with the compounds according to the present invention comprise cereals (corn, barley, rye, oats, rice, maize, sorghum, etc.), fruit trees (apples, pears, plums, peaches, almonds, cherries, bananas, vines, strawberries, raspberries, blackberries, etc.), citrus trees (oranges, lemons, mandarin oranges, grapefruits, etc.), leguminous plants (beans, peas, lentils, soybean, etc.), horticultural plants (spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, aubergines, peppers, etc.), cucurbitaceae (pumpkins, courgettes, cucumbers, melons, water-melons, etc.), oleaginous plants (sunflower, rape, peanut, castor oil plant, coconut, etc.), tobacco, coffee, tea, cacao, sugar beet, sugar cane, cotton.

In particular, the compounds having formula (I) have proved to be extremely effective in the control of Phytophtora infestans and Botrytis Cinerea on tomatoes; Puccinia recondita, Erisiphae graminis, Helminthosporium teres, Septoria nodorum and Fusarium spp. on cereals, in the control of Phakopsora pachyrhizi on soybean, in the control of Uromyces Appendiculatus on beans, in the control of Venturia inaequalis on apple trees, in the control of Sphaerotheca fuliginea on cucumbers.

Furthermore, the compounds having formula (I) are also effective in the control of bacteria and phytopathogenic viruses, such as for example Xanthomonas spp., Pseudomonas spp., Erwinia amylovora , tobacco mosaic virus.

The compounds having formula (I) are capable of exerting a fungicidal action of both a curative and preventive nature and have an extremely low or zero phytotoxicity on the crops treated.

A further object of the present invention therefore relates to the use of the compounds having formula (I) for the control of phytopathogenic fungi of agricultural crops.

For practical uses in agriculture, it is often preferable to use fungicidal compositions containing the compounds of the present invention suitably formulated.

A further object of the present invention relates to fungicidal compositions comprising one or more compounds having formula (I), a solvent and/or solid or liquid diluent, optionally a surface-active agent.

The above fungicidal compositions can be in the form of dry powders, wettable powders, emulsifying concentrates, emulsions, microemulsions, pastes, granulates, water dispersible granules, solutions, suspensions, etc.: the choice of the type of composition will depend on the specific use.

The fungicidal compositions are prepared in the known way, for example by diluting or dissolving the active substance with a solvent medium and/or a solid or liquid diluent, optionally in the presence of surfactants.

Solid diluents or supports which can be used for example are: silica, kaolin, bentonite, talc, infusorial earth, dolomite, calcium carbonate, magnesia, gypsum, clays, synthetic silicates, attapulgite, sepiolite.

Liquid solvents or diluents which can be used, are for example, in addition to water, aromatic organic solvents (xylols or blends of alkylbenzols, chlorobenzene, etc.), paraffins (petroleum fractions), alcohols (methanol, propanol, butanol, octanol, glycerine, etc.), esters (ethyl acetate, isobutyl acetate, alkyl carbonates, alkyl esters of adipic acid, alkyl esters of glutaric acid, alkyl esters of succinic acid, alkyl esters of lactic acid, etc.), vegetable oils (rape oil, sunflower oil, soybean oil, castor oil, corn oil, peanut oil, and their alkyl esters), ketones (cyclohexanone, acetone, acetophenone, isophorone, ethylamylketone, etc.), amides (N,N-dimethylformamide, N-methylpyrrolidone, etc.), sulfoxides and sulfones (dimethylsulfoxide, dimethylsulfone, etc.), and mixtures thereof.

Sodium salts, calcium salts, potassium salts, salts of triethylamine or triethanolamine of alkylnaphthalenesulfonates, polynaphthalenesulfonates, alkyl sulfonates, aryl sulfonates, alkylaryl sulfonates, polycarboxylates, sulfosuccinates, alkyl sulfosuccinates, ligninsulfonates, alkyl sulfates, can be used as surfactants; as also polyethoxylated fatty alcohols, polyethoxylated alkylphenols, polyethoxylated esters of sorbitol, polypropoxy polyethoxylates (block polymers).

The fungicidal compositions can also contain special additives for particular purposes, such as for example, antifreeze agents such as propylene glycol, or adhesive agents, such as Arabic rubber, polyvinyl alcohol, polyvinyl pyrrolidone, etc.

When desired, other compatible active principles can be added to the fungicidal compositions containing the compounds of general formula (I), such as, for example, fungicides different from those having general formula (I), phytoregulators, antibiotics, herbicides, insecticides, fertilizers and/or mixtures thereof.

Examples of fungicides different from those having general formula (I) which can be included in the fungicidal compositions of the present invention are: acibenzolar, ametoctradin, amisulbrom, ampropylfos, anilazine, azaconazole, azoxystrobin, benalaxyl, benalaxyl-M, benomyl, benthiavalicarb, bitertanol, bixafen, blasticidin-S, boscalid, bromuconazole, bupirimate, buthiobate, captafol, captan, carbendazim, carboxin, carpropamid, chinomethionat, chloroneb, chlorothalonil, chlozolinate, cyazofamid, cyflufenamid, cymoxanil, cyproconazole, cyprodinil, debacarb, dichlofluanid, dichlone, diclobutrazol, diclomezine, dicloran, diclocymet, diethofencarb, difenoconazole, diflumetorim, dimethirimol, dimethomorph, dimoxystrobin, diniconazole, dinocap, dipyrithione, ditalimfos, dithianon, dodemorph, dodine, edifenphos, epoxiconazole, etaconazole, ethaboxam, ethirimol, ethoxyquin, etridiazole, famoxadone, fenamidone, fenaminosulf, fenapanil, fenarimol, fenbuconazole, fenfuram, fenhexamid, fenoxanil, fenpiclonil, fenpropidin, fenpropimorph, fenpyrazamine, fentin, ferbam, ferimzone, fluazinam, fludioxonil, flumetover, flumorph, fluopicolide, fluopyram, fluoroimide, fluotrimazole, fluoxastrobin, fluquinconazole, flusilazole, flusulfamide, flutianil, flutolanil, flutriafol, fluxapyroxad, folpet, fosetylaluminium, fuberidazole, furalaxyl, furametpyr, furconazole, furconazole-cis, guazatine, hexaconazole, hymexazol, hydroxyquinoline sulfate, imazalil, imibenconazole, iminoctadine, ipconazole, iprobenfos, iprodione, isoprothiolane, iprovalicarb, isopyrazam, isotianil, kasugamycin, kresoxim-methyl, mancopper, mancozeb, mandipropamid, maneb, mebenil, mepanipyrim, mepronil, meptyldinocap, metalaxyl, metalaxyl-M, metconazole, methfuroxam, metiram, metominostrobin, metrafenone, metsulfovax, myclobutanil, natamycin, nicobifen, nitrothal-isopropyl, nuarimol, ofurace, orysastrobin, oxadixyl, oxpoconazole, oxycarboxin, pefurazoate, penconazole, pencycuron, penflufen, pentachlorofenol e suoi sali, penthiopyrad, phthalide, picoxystrobin, piperalin, Bordeaux mixture, polyoxins, probenazole, prochloraz, procymidone, propamocarb, propiconazole, propineb, proquinazid, prothiocarb, prothioconazole, pyracarbolid, pyraclostrobin, pyrametostrobin, pyraoxystrobin, pyrazophos, pyribencarb, pyrifenox, pyrimethanil, pyriofenone, pyroquilon, pyroxyfur, quinacetol, quinazamid, quinconazole, quinoxyfen, quintozene, rabenzazole, copper hydroxide, copper oxychloride, copper (I) oxide, copper sulfate, sedaxane, silthiofam, simeconazole, spiroxamine, streptomycin, tebuconazole, tebufloquin, tetra-conazole, thiabendazole, thiadifluor, thicyofen, thifluzamide, thiophanate, thiophanate-methyl, thiram, tiadinil, tioxymid, tolclofosmethyl, tolylfluanid, triadimefon, triadimenol, triarimol, triazbutil, triazoxide, tricyclazole, tridemorf, trifloxystrobin, triflumizole, triforine, triticonazole, uniconazole, uniconazole-P, validamycin, valifenalate, vinclozolin, zineb, ziram, sulfur, zoxamide.

›The concentration of phenylamidine compounds having general formula…

The concentration of phenylamidine compounds having general formula (I) in the above compositions can vary within a wide range; it generally ranges from 1% to 90% by weight with respect to the total weight of the composition, preferably from 5% to 50% by weight with respect to the total weight of the composition.

The application of these compositions can be effected on all parts of the plant, for example on the leaves, stems, branches and roots, or on the seeds themselves before sowing, or on the ground in which the plant grows.

A further object of the present invention therefore relates to a method for the control of phytopathogenic fungi in agricultural crops, which consists in the application of effective dosages of the compounds of formula (I), used as such or formulated in fungicidal compositions as described above.

The quantity of compound to be applied for obtaining the desired effect can vary in relation to different factors, such as, for example, the compound used, the crop to be preserved, the type of pathogen, the degree of infection, the climatic conditions, the application method, the formulation adopted.

Doses of compound ranging from 10 g to 5 kg per hectare of agricultural crop generally provide a sufficient control.

The following examples are provided for a better understanding of the invention for illustrative and non-limiting purposes of the same.

›Examples9
›EXAMPLE 1

Preparation of 2-nitro-5-(3-difluoromethoxyphenylthio)-p-xylene [nitroderivative of formula (III)]

4.36 g (0.109 moles) of sodium hydride are suspended in 80 ml of N,N-dimethylformamide at 0° C. 20 g of 4-nitro-2,5-dimethylthiophenol (0.109 moles) dissolved in 67 ml of N,N-dimethylformamide are added dropwise under stirring. 24.4 g of 1-bromo-3-(difluoromethoxy)benzene (0.109 moles) dissolved in 20 ml of N,N-dimethylformamide are then added dropwise; catalytic Cu° and CuCl are subsequently added and the reaction temperature is brought to 150° C. for 1 h.

After GC control, the reaction mixture is cooled to room temperature, filtered on a celite bed, diluted with water and extracted with ethyl acetate. The organic phase is anhydrified with sodium sulfate, and then filtered and evaporated.

The product thus obtained is purified on silica gel eluting with hexane/ethyl acetate 9:1. 30 g of the desired product are obtained. GC-MS: M + =325

›EXAMPLE 2

Preparation of 4-(3-difluoromethoxyphenylthio)-2,5-xylidine [aniline of formula (II)]

7.7 ml of glacial acetic acid (0.135 moles) are added to a solution of 30 g of 2-nitro-5-(3-difluoromethoxyphenylthio)-p-xylene (0.092 moles) in H 2 O (40 ml) and ethanol (400 ml); 34.7 g of Fe in powder form (0.621 moles) are carefully added to the reaction mixture kept under stirring at 60° C. The temperature is brought to 90° C. and the mixture is kept under stirring for 1.5 hours. When the reaction is completed (GC and TLC analyses), the mixture is cooled to room temperature; the solid is filtered on a celite bed. The ethanol is concentrated at reduced pressure. The crude product obtained is washed with a saturated solution of sodium bicarbonate and extracted with ethyl acetate.

The organic phase is washed with H 2 O, anhydrified on sodium sulfate, filtered and evaporated to give 25 g of the desired product. GC-MS: M + =295

ESEMPIO 3

Preparation of N-ethyl-N-methyl-N′-[4-(3-difluoromethoxyphenylthio)-2,5-xylyl]formamidine [Compound N.1]

Catalytic p-toluenesulfonic acid is added to a mixture of 25 g of 4-(3-difluoromethoxyphenylthio)-2,5-xylidine (0.085 moles) and 141 ml of triethylorthoformiate (0.85 moles). The temperature is brought to reflux and the mixture is kept under stirring for 3 hours. The reaction trend is controlled with TLC (eluent hexane/ethyl acetate 8:2). When the reaction is completed, the mixture is concentrated at reduced pressure and the raw product obtained dissolved in methylene chloride (234 ml); 14.3 ml of N-ethylmethylamine (0.17 moles) are added dropwise. The mixture is kept under stirring for 3 hours at 40° C. and, after TLC control (eluent hexane/ethyl acetate 8:2), is concentrated at reduced pressure. 20 g of the desired product are obtained.

GC-MS: M + =364. 1 H-NMR (CDCl 3 ) δ=1.19 (t, 3H); 2.20 (s, 3H); 2.28 (s, 3H); 2.97 (s, 3H); 3.35 (bq, 2H); 6.65 (t, 1H); 6.70 (bs, 1H); 6.80 (bs, 1H); 6.85-7.35 (c, 4H); 7.50 (bs, 1H)

›EXAMPLE 4

Preparation of 2-nitro-5-(3-hydroxyphenylthio)-p-xylene [nitroderivative of formula (IV)]

A mixture of 18.9 g of 3-mercaptophenol (0.150 moles), 32.9 g of 2-nitro-5-bromo-p-xylene (0.143 moles) and K 2 CO 3 (0.143 moles) in 95 ml of N,N-dimethylformamide is stirred at room temperature for 2 hours. A solution of HCl at 10% is added under stirring; the mixture is diluted with H 2 O and extracted with ethyl acetate. The organic phase is washed again with water, anhydrified on sodium sulfate, filtered and evaporated. 20 g of solid product are obtained, which is used as such for the subsequent reaction.

GC-MS: M + =275

›EXAMPLE 5

Preparation of 4-(3-hydroxyphenylthio)-2,5-xylidine

6.3 ml of glacial acetic acid (0.11 moles) are added to a solution of 20 g of the product obtained in Example 4 (0.076 moles) in 328 ml of ethanol and 33 ml of H 2 O; 29.7 g of Fe in powder form (0.53 moles) are carefully added to the reaction mixture kept under stirring at 60° C. The temperature is brought to 90° C. and the mixture is kept under stirring for 1.5 hours.

When the reaction is complete (GC and TLC analyses), the mixture is cooled to room temperature; the solid is filtered on a celite bed. The ethanol is concentrated at reduced pressure. The product obtained is washed with a saturated solution of sodium bicarbonate and extracted with ethyl acetate. The organic phase is washed with H 2 O, anhydrified on sodium sulfate, filtered and evaporated to give 15 g of the desired product.

GC-MS: M + =245

›EXAMPLE 6

Preparation of N-ethyl-N-methyl-N′-[4-(3-hydroxyphenylthio)-2,5-xylyl]formamidine

Catalytic p-toluenesulfonic acid is added to a mixture of 15 g (0.06 moles) of product obtained as described in Example 5 and 100 ml of triethylorthoformiate (0.6 moles). The temperature is brought to reflux and the mixture kept under stirring for 3 hours. The reaction trend is controlled with TLC (eluent hexane/ethyl acetate 8:2). When the reaction is complete, the reaction mixture is concentrated at reduced pressure and the raw product obtained dissolved in 165 ml of methylene chloride; 10 ml of N-ethylmethylamine are added dropwise. The mixture is kept under stirring for 3 hours at 40° C. After TLC control (eluent hexane/ethyl acetate 8:2), the reaction mixture is concentrated at reduced pressure. 18 g of the desired product are obtained, used as such in example 7. GC-MS: M + =314

›EXAMPLE 7

Preparation of N-ethyl-N-methyl-N′-{4-[3-(1,1,2,2-tetrafluoroethoxy)phenylthio]-2,5-xylyl}formamidine [Compound N. 2]

4.7 g of N-ethyl-N-methyl-N′-[4-(3-hydroxyphenylthio)-2,5-xylyl]formamidine (0.015 moles), obtained as described in Example 6, and 1.0 g of KOH (0.015 moles) are suspended in 43 ml of anhydrous toluene and 198 ml of dimethylsulfoxide. The mixture is cooled to −25° C.; a vacuum is created in the apparatus and tetrafluoroethylene is fed. After an hour, the reaction mixture is brought back to room temperature and controlled by means of TLC (hexane/ethyl acetate 7:3).

The reaction is diluted with water and extracted with ethyl acetate; the organic phase is anhydrified with sodium sulfate and concentrated to give 5.7 g of residue. The crude product thus obtained is purified by means of a silica gel chromatographic column eluting with hexane/ethyl acetate/triethylamine 97:2:1.

GC-MS: M + =414. 1 H-NMR (CDCl 3 ) δ=1.19 (t, 3H); 2.20 (s, 3H); 2.28 (s, 3H); 2.98 (s, 3H); 3.37 (bq, 2H); 5.85 (tt, 1H); 6.72 (bs, 1H); 6.82 (bs, 1H); 6.85-7.35 (c, 4H); 7.50 (bs, 1H)

›EXAMPLE 8

Preparation of compounds N. 3-107

Operating analogously to what is described in the previous examples, the compounds having formula (I) reported in Table 2 were obtained.

The compounds were obtained as dense oils. The GC-MS (M + ) and 1 H-NMR (CDCl 3 ) data for the most representative compounds are reported in Table 3.

›EXAMPLE 9

Determination of the Fungicidal Activity in Preventive Application (5 Days) Against Erysiphe graminis on Wheat

Leaves of wheat plants of the Salgemma variety, grown in pots in a conditioned environment kept at 20° C. and 70% of relative humidity (R.H.), were treated by spraying on both sides of the leaves with the compounds under examination, dispersed in hydroacetonic solutions at 20% by volume of acetone.

After remaining 5 days in a conditioned environment, the plants were infected under dry conditions by shaking over them, in order to distribute the inoculum, plants previously infected by Erysiphe graminis.

The plants were then maintained in the same cell, in a humidity-saturated environment and at a temperature ranging from 18 to 24° C. for 12 days.

At the end of this period, the external symptoms of the pathogen appeared and it was therefore possible to proceed with the evaluation of the intensity of the infection, on both the parts treated directly with the products (T), and also on the parts which had developed during the test (NT), by means of a visible percentage evaluation scale of the area of affected leafs; the scale comprises, as extremes, the value 100 (healthy plant) and the value 0 (completely infected plant).

All the compounds N. 1-107 showed a full activity (100%) at a dose of 500 p.p.m

At the same time, the phytotoxicity was evaluated (percentage of leaf necrosis) induced on the wheat plants by the application of the products: in this case, the evaluation scale varies from 0 (completely healthy plant) to 100 (completely necrotized plant).

Table 4 shows the results obtained by effecting the test described with compounds N. 1, 2, 15, 19 and 23, compared with the following reference products described in Table 1 of WO 00/46184:

N,N-dimethyl-N′-[4-(3-trifluoromethylphenoxy)-2,5-xylyl]-formamidine (compound N. 1: CR-1); N,N-dimethyl-N′-[4-(3-trifluoromethylphenylthio)-2,5-xylyl]-formamidine (compound N. 4: CR-2); N-ethyl-N-methyl-N′-[4-(3-trifluoromethylphenoxy)-2,5-xylyl]formamidine (compound N. 45: CR-3); N,N-dimethyl-N′-[4-(3-trifluoromethoxyphenoxy)-2,5-xylyl]formamidine (compound N. 190: CR-4); N,N-dimethyl-N′-{4-[3-(2,2,2-trifluoroethoxy)phenoxy]-2,5-xylyl}formamidine (compound N. 359: CR-5)

The compounds N. 1, 2, 15, 19 and 23 proved to be less phytotoxic and/or more active with respect to the reference products.

›EXAMPLE 10

Determination of the Fungicidal Activity in Preventive Application (5 Days) Against Puccinia recondita on Wheat

Leaves of wheat plants of the Salgemma variety, grown in pots in a conditioned environment kept at 20° C. and 70% of relative humidity (R.H.), were treated by spraying on both sides of the leaves with the compounds under examination, dispersed in hydroacetonic solutions at 20% by volume of acetone.

After remaining 5 days in a conditioned environment, the plants were sprayed on both sides of the leafs with an aqueous suspension of conidia of Puccinia recondita (2 mg of inoculum per 1 ml of solution for infection).

After being sprayed, the plants were kept in a humidity-saturated environment at a temperature ranging from 18 to 24° C. for the incubation period of the fungus (1 day).

After this period, the plants were put in a greenhouse with R.H. of 70% and at a temperature of 18-24° C. for 14 days.

At the end of this period, the external symptoms of the pathogen appeared and it was therefore possible to proceed with the evaluation of the intensity of the infection, on both the parts treated directly with the products (T), and also on the parts which had developed during the test (NT), by means of a visible percentage evaluation scale of the area of affected leafs; the scale comprises, as extremes, the value 100 (healthy plant) and the value 0 (completely infected plant).

All the compounds N. 1-107 showed a full activity (100%) at a dose of 500 p.p.m

At the same time, the phytotoxicity was evaluated (percentage of leaf necrosis) induced on the wheat plants by the application of the products: in this case, the evaluation scale varies from 0 (completely healthy plant) to 100 (completely necrotized plant).

Table 5 shows the results obtained by effecting the test described with compounds N. 1, 2, 15, 19 and 23, compared with the following reference products described in Table 1 of WO 00/46184:

N,N-dimethyl-N′-[4-(3-trifluoromethylphenoxy)-2,5-xylyl]-formamidine (compound N. 1: CR-1); N,N-dimethyl-N′-[4-(3-trifluoromethylphenylthio)-2,5-xylyl]-formamidine (compound N. 4: CR-2); N-ethyl-N-methyl-N′-[4-(3-trifluoromethylphenoxy)-2,5-xylyl]formamidine (compound N. 45: CR-3); N,N-dimethyl-N′-[4-(3-trifluoromethoxyphenoxy)-2,5-xylyl]formamidine (compound N. 190: CR-4); N,N-dimethyl-N′-{4-[3-(2,2,2-trifluoroethoxy)phenoxy]-2,5-xylyl}formamidine (compound N. 359: CR-5)

The compounds N. 1, 2, 15, 19 and 23 proved to be less phytotoxic and/or more active with respect to the reference products.

›Tables in the description — 5
TABLE 1
RR 1R 2R 3R 4
3-HCF 2 CF 2 O-phenylEtMeMeMe
3-HCF 2 CF 2 S-phenylEtMeMeMe
3-HCF 2 CF 2 O-phenyli-PrMeMeMe
3-HCF 2 CF 2 O-phenyln-PrMeMeMe
3-HCF 2 CF 2 O-phenyl—(CH 2 ) 4 —MeMe
3-HCF 2 CF 2 O-phenyl—(CH 2 ) 5 —MeMe
3-HCF 2 CF 2 O-phenyl—CH 2 CH 2 OCH 2 CH 2 —MeMe
3-HCF 2 CF 2 O-phenylEtMeHMe
3-HCF 2 CF 2 O-phenylEtMeMeCF 3
3-HCF 2 CF 2 O-phenylEtMeMeCF 2 H
3-HCF 2 CF 2 O-phenylEtMeHCF 3
3-HCF 2 CF 2 O-phenylEtMeCF 2 HMe
3-HCF 2 CF 2 O-phenylEtMeClCl
3-HCF 2 CF 2 O-phenylEtMeMeCl
3-HCF 2 CF 2 O-phenylEtMeMeH
3-HCF 2 CF 2 O-phenylEtMeHMe
3-HCF 2 CF 2 O-phenylEtMeMeCN
3-HCF 2 CF 2 O-phenylEtMeMeOMe
3-HCF 2 CF 2 S-phenylEtMeMeMe
4-HCF 2 CF 2 O-phenylEtMeMeMe
4-HCF 2 CF 2 O-phenyl—(CH 2 ) 4 —MeMe
4-HCF 2 CF 2 O-phenyl—(CH 2 ) 5 —MeMe
4-HCF 2 CF 2 O-phenyl—CH 2 CH 2 OCH 2 CH 2 —MeMe
4-HCF 2 CF 2 S-phenylEtMeMeMe
3-HCF 2 O-phenylEtMeMeMe
3-HCF 2 O-phenyl—(CH 2 ) 4 —MeMe
3-HCF 2 O-phenyl—(CH 2 ) 5 —MeMe
3-HCF 2 O-phenyl—CH 2 CH 2 OCH 2 CH 2 —MeMe
3-HCF 2 S-phenylEtMeMeMe
4-HCF 2 O-phenylEtMeMeMe
4-HCF 2 O-phenyl—(CH 2 ) 4 —MeMe
4-HCF 2 O-phenyl—(CH 2 ) 5 —MeMe
4-HCF 2 O-phenyl—CH 2 CH 2 OCH 2 CH 2 —MeMe
4-HCF 2 S-phenylEtMeMeMe
3-CF 3 CH 2 O-phenylEtMeMeMe
3-CF 3 CH 2 O-phenyl—(CH 2 ) 4 —MeMe
3-CF 3 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
3-CF 3 CH 2 O-phenyl—CH 2 CH 2 OCH 2 CH 2 —MeMe
3-CF 3 CH 2 S-phenylEtMeMeMe
4-CF 3 CH 2 O-phenylEtMeMeMe
4-CF 3 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
3-HCF 2 CF 2 CH 2 O-phenylEtMeMeMe
3-HCF 2 CF 2 CH 2 O-phenyl—(CH 2 ) 4 —MeMe
3-HCF 2 CF 2 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
3-HCF 2 CF 2 CH 2 O-phenyl—CH 2 CH 2 OCH 2 CH 2 —MeMe
4-HCF 2 CF 2 CH 2 O-phenylEtMeMeMe
3-HCF 2 CF 2 CH 2 S-phenylEtMeMeMe
4-HCF 2 CF 2 CH 2 O-phenyl—(CH 2 ) 4 —MeMe
4-HCF 2 CF 2 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
4-HCF 2 CF 2 CH 2 O-phenyl—CH 2 CH 2 OCH 2 CH 2 —MeMe
3-CF 3 CF 2 CH 2 O-phenylEtMeMeMe
3-CF 3 CF 2 CH 2 O-phenyl—(CH 2 ) 4 —MeMe
3-CF 3 CF 2 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
4-CF 3 CF 2 CH 2 O-phenylEtMeMeMe
4-CF 3 CF 2 CH 2 O-phenyl—(CH 2 ) 4 —MeMe
4-CF 3 CF 2 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
3-CF 3 CHFCF 2 O-phenylEtMeMeMe
4-CF 3 CHFCF 2 O-phenylEtMeMeMe
3-CF 3 CHFCF 2 CH 2 O-phenylEtMeMeMe
4-CF 3 CHFCF 2 CH 2 O-phenylEtMeMeMe
3-HCF 2 CF 2 CF 2 CF 2 CH 2 O-phenylEtMeMeMe
4-HCF 2 CF 2 CF 2 CF 2 CH 2 O-phenylEtMeMeMe
4-F-3-HCF 2 O-phenylEtMeMeMe
4-F-3-HCF 2 O-phenyl—(CH 2 ) 5 —MeMe
4-Cl-3-HCF 2 O-phenylEtMeMeMe
4-Cl-3-HCF 2 O-phenyl—(CH 2 ) 5 —MeMe
4-Me-3-HCF 2 O-phenylEtMeMeMe
2,4-F 2 -3-HCF 2 O-phenylEtMeMeMe
4,5-F 2 -3-HCF 2 O-phenylEtMeMeMe
2-F-3-HCF 2 O-phenylEtMeMeMe
5-F-3-HCF 2 O-phenylEtMeMeMe
3-F-4-HCF 2 O-phenylEtMeMeMe
3-F-4-HCF 2 O-phenyl—(CH 2 ) 5 —MeMe
3-Cl-4-HCF 2 O-phenylEtMeMeMe
3-Cl-4-HCF 2 O-phenyl—(CH 2 ) 5 —MeMe
3-Me-4-HCF 2 O-phenylEtMeMeMe
3-CF 3 -4-HCF 2 O-phenylEtMeMeMe
2-F-4-HCF 2 O-phenylEtMeMeMe
2-Cl-4-HCF 2 O-phenylEtMeMeMe
3,5-F 2 -4-HCF 2 O-phenylEtMeMeMe
4-F-3-HCF 2 CF 2 O-phenylEtMeMeMe
4-F-3-HCF 2 CF 2 O-phenyl—(CH 2 ) 5 —MeMe
4-Cl-3-HCF 2 CF 2 O-phenylEtMeMeMe
4-Cl-3-HCF 2 CF 2 O-phenyl—(CH 2 ) 5 —MeMe
4-Me-3-HCF 2 CF 2 O-phenylEtMeMeMe
2,4-F 2 -3-HCF 2 CF 2 O-phenylEtMeMeMe
4,5-F 2 -3-HCF 2 CF 2 O-phenylEtMeMeMe
2-F-3-HCF 2 CF 2 O-phenylEtMeMeMe
5-F-3-HCF 2 CF 2 O-phenylEtMeMeMe
3-F-4-HCF 2 CF 2 O-phenylEtMeMeMe
3-F-4-HCF 2 CF 2 O-phenyl—(CH 2 ) 5 —MeMe
3-Cl-4-HCF 2 CF 2 O-phenylEtMeMeMe
3-Cl-4-HCF 2 CF 2 O-phenyl—(CH 2 ) 5 —MeMe
3-Me-4-HCF 2 CF 2 O-phenylEtMeMeMe
3-CF 3 -4-HCF 2 CF 2 O-phenylEtMeMeMe
2-F-4-HCF 2 CF 2 O-phenylEtMeMeMe
2-Cl-4-HCF 2 CF 2 O-phenylEtMeMeMe
3,5-F 2 -4-HCF 2 CF 2 O-phenylEtMeMeMe
4-F-3-CF 3 CH 2 O-phenylEtMeMeMe
4-F-3-CF 3 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
4-Cl-3-CF 3 CH 2 O-phenylEtMeMeMe
4-Cl-3-CF 3 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
4-Me-3-CF 3 CH 2 O-phenylEtMeMeMe
2,4-F 2 -3-CF 3 CH 2 O-phenylEtMeMeMe
4,5-F 2 -3-CF 3 CH 2 O-phenylEtMeMeMe
2-F-3-CF 3 CH 2 O-phenylEtMeMeMe
5-F-3-CF 3 CH 2 O-phenylEtMeMeMe
3-F-4-CF 3 CH 2 O-phenylEtMeMeMe
3-F-4-CF 3 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
3-Cl-4-CF 3 CH 2 O-phenylEtMeMeMe
3-Cl-4-CF 3 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
3-Me-4-CF 3 CH 2 O-phenylEtMeMeMe
2-F-4-CF 3 CH 2 O-phenylEtMeMeMe
2-Cl-4-CF 3 CH 2 O-phenylEtMeMeMe
3,5-F 2 -4-CF 3 CH 2 O-phenylEtMeMeMe
4-F-3-HCF 2 CF 2 CH 2 O-phenylEtMeMeMe
4-F-3-HCF 2 CF 2 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
4-Cl-3-HCF 2 CF 2 CH 2 O-phenylEtMeMeMe
4-Cl-3-HCF 2 CF 2 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
4-Me-3-HCF 2 CF 2 CH 2 O-phenylEtMeMeMe
2,4-F 2 -3-HCF 2 CF 2 CH 2 O-phenylEtMeMeMe
4,5-F 2 -3-HCF 2 CF 2 CH 2 O-phenylEtMeMeMe
2-F-3-HCF 2 CF 2 CH 2 O-phenylEtMeMeMe
5-F-3-HCF 2 CF 2 CH 2 O-phenylEtMeMeMe
3-F-4-HCF 2 CF 2 CH 2 O-phenylEtMeMeMe
3-F-4-HCF 2 CF 2 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
3-Cl-4-HCF 2 CF 2 CH 2 O-phenylEtMeMeMe
3-Cl-4-HCF 2 CF 2 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
3-Me-4-HCF 2 CF 2 CH 2 O-phenylEtMeMeMe
2-F-4-HCF 2 CF 2 CH 2 O-phenylEtMeMeMe
2-Cl-4-HCF 2 CF 2 CH 2 O-phenylEtMeMeMe
3,5-F 2 -4-HCF 2 CF 2 CH 2 O-phenylEtMeMeMe
5-HCF 2 CF 2 O-2-pyridylEtMeMeMe
5-HCF 2 O-2-pyridylEtMeMeMe
5-CF 3 CH 2 O-2-pyridylEtMeMeMe
5-HCF 2 CF 2 CH 2 O-2-pyridylEtMeMeMe
2-HCF 2 CF 2 O-4-pyridylEtMeMeMe
2-HCF 2 O-4-pyridylEtMeMeMe
2-CF 3 CH 2 O-4-pyridylEtMeMeMe
2-HCF 2 CF 2 CH 2 O-4-pyridylEtMeMeMe
2-HCF 2 CF 2 O-5-pyridylEtMeMeMe
2-HCF 2 O-5-pyridylEtMeMeMe
2-CF 3 CH 2 O-5-pyridylEtMeMeMe
2-HCF 2 CF 2 O-5-pyrimidylEtMeMeMe
2-HCF 2 O-5-pyrimidylEtMeMeMe
2-CF 3 CH 2 O-5-pyrimidylEtMeMeMe
5-HCF 2 CF 2 O-2-pyrazylEtMeMeMe
5-HCF 2 O-2-pyrazylEtMeMeMe
5-CF 3 CH 2 O-2-pyrazylEtMeMeMe
6-HCF 2 CF 2 O-3-pyridazylEtMeMeMe
6-HCF 2 O-3-pyridazylEtMeMeMe
6-CF 3 CH 2 O-3-pyridazylEtMeMeMe
3-cyclohexyl-phenylEtMeMeMe
4-cyclohexyl-phenylEtMeMeMe
3-cyclopentyl-phenylEtMeMeMe
4-cyclopentyl-phenylEtMeMeMe
3-cyclopropyl-phenylEtMeMeMe
4-cyclopropyl-phenylEtMeMeMe
3-cyclopropyl-phenyl—(CH 2 ) 5 —MeMe
3-(2,2-Cl 2 -cyclopropyl)-EtMeMeMe
phenyl
3-(2,2-F 2 -cyclopropyl)-EtMeMeMe
phenyl
3-(cyclopentoxy)-phenylEtMeMeMe
4-(cyclopentoxy)-phenylEtMeMeMe
3-(cyclopentoxy)-phenyl—(CH 2 ) 5 —MeMe
4-(cyclopentoxy)-phenyl—(CH 2 ) 5 —MeMe
3-(cyclohexyloxy)-phenylEtMeMeMe
4-(cyclohexyloxy)-phenylEtMeMeMe
3-(cyclopropylmethoxy)-EtMeMeMe
phenyl
4-(cyclopropylmethoxy)-EtMeMeMe
phenyl
3-(cyclopropylmethoxy)-—(CH 2 ) 5 —MeMe
phenyl
4-(cyclopropylmethoxy)-—(CH 2 ) 5 —MeMe
phenyl
3-(2,2-Cl 2 -cyclopropyl-EtMeMeMe
methoxy)-phenyl
4-2,2-Cl 2 -cyclopropyl-EtMeMeMe
methoxy)-phenyl
3-(2,2-F 2 -cyclopropyl-EtMeMeMe
methoxy)-phenyl
4-(2,2-F 2 -cyclopropyl-EtMeMeMe
methoxy)-phenyl
3-cyclohexylmethoxy-EtMeMeMe
phenyl
5-cyclopentoxy-2-pyridylEtMeMeMe
5-(cyclopropylmethoxy)-EtMeMeMe
2-pyridyl
2-cyclopentoxy-5-EtMeMeMe
pyrimidyl
2-(cyclopropylmethoxy)-EtMeMeMe
5-pyrimidyl
5-cyclopentoxy-2-pyrazylEtMeMeMe
5-(cyclopropylmethoxy)-EtMeMeMe
2-pyrazyl
6-cyclopentoxy-3-EtMeMeMe
pyridazyl
6-(cyclopropylmethoxy)-EtMeMeMe
3-pyridazyl
TABLE 2
N.RR 1R 2R 3R 4
33-HCF 2 CF 2 O-phenyli-PrMeMeMe
43-HCF 2 CF 2 O-phenyln-PrMeMeMe
53-HCF 2 CF 2 O-phenyl—(CH 2 ) 4 —MeMe
63-HCF 2 CF 2 O-phenyl—(CH 2 ) 5 —MeMe
73-HCF 2 CF 2 O-phenyl—CH 2 CH 2 OCH 2 CH 2 —MeMe
84-HCF 2 CF 2 O-phenylEtMeMeMe
94-HCF 2 CF 2 O-phenyl—(CH 2 ) 5 —MeMe
104-HCF 2 O-phenylEtMeMeMe
113-HCF 2 O-phenyl—(CH 2 ) 4 —MeMe
123-HCF 2 O-phenyl—(CH 2 ) 5 —MeMe
133-HCF 2 O-phenyl—CH 2 CH 2 OCH 2 CH 2 —MeMe
144-HCF 2 O-phenyl—(CH 2 ) 5 —MeMe
153-CF 3 CH 2 O-phenylEtMeMeMe
163-CF 3 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
174-CF 3 CH 2 O-phenylEtMeMeMe
184-CF 3 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
193-HCF 2 CF 2 CH 2 O-phenylEtMeMeMe
203-HCF 2 CF 2 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
214-HCF 2 CF 2 CH 2 O-phenylEtMeMeMe
224-HCF 2 CF 2 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
233-CF 3 CF 2 CH 2 O-phenylEtMeMeMe
243-CF 3 CF 2 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
254-CF 3 CF 2 CH 2 O-phenylEtMeMeMe
264-CF 3 CF 2 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
274-Cl-3-HCF 2 CF 2 O-phenylEtMeMeMe
284-Me-3-HCF 2 CF 2 O-phenylEtMeMeMe
293-Cl-4-HCF 2 CF 2 O-phenylEtMeMeMe
303-Me-4-HCF 2 CF 2 O-phenylEtMeMeMe
313-CF 3 -4-HCF 2 CF 2 O-phenylEtMeMeMe
324-Cl-3-HCF 2 CF 2 O-phenyl—(CH 2 ) 5 —MeMe
334-Me-3-HCF 2 CF 2 O-phenyl—(CH 2 ) 5 —MeMe
343-Cl-4-HCF 2 CF 2 O-phenyl—(CH 2 ) 5 —MeMe
353-Me-4-HCF 2 CF 2 O-phenyl—(CH 2 ) 5 —MeMe
363-CF 3 -4-HCF 2 CF 2 O-phenyl—(CH 2 ) 5 —MeMe
374-F-3-HCF 2 CF 2 O-phenylEtMeMeMe
383-F-4-HCF 2 CF 2 O-phenylEtMeMeMe
394-F-3-HCF 2 CF 2 O-phenyl—(CH 2 ) 5 —MeMe
403-F-4-HCF 2 CF 2 O-phenyl—(CH 2 ) 5 —MeMe
414-Cl-3-HCF 2 O-phenylEtMeMeMe
423-Cl-4-HCF 2 O-phenylEtMeMeMe
434-Cl-3-HCF 2 O-phenyl—(CH 2 ) 5 —MeMe
443-Cl-4-HCF 2 O-phenyl—(CH 2 ) 5 —MeMe
454-F-3-HCF 2 O-phenylEtMeMeMe
463-F-4-HCF 2 O-phenylEtMeMeMe
474-F-3-HCF 2 O-phenyl—(CH 2 ) 5 —MeMe
483-F-4-HCF 2 O-phenyl—(CH 2 ) 5 —MeMe
494-Cl-3-CF 3 CH 2 O-phenylEtMeMeMe
503-Cl-4-CF 3 CH 2 O-phenylEtMeMeMe
514-Cl-3-CF 3 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
523-Cl-4-CF 3 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
534-F-3-CF 3 CH 2 O-phenylEtMeMeMe
543-F-4-CF 3 CH 2 O-phenylEtMeMeMe
554-F-3-CF 3 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
563-F-4-CF 3 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
574-Cl-3-HCF 2 CF 2 CH 2 O-phenylEtMeMeMe
583-Cl-4-HCF 2 CF 2 CH 2 O-phenylEtMeMeMe
594-Cl-3-HCF 2 CF 2 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
603-Cl-4-HCF 2 CF 2 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
614-F-3-HCF 2 CF 2 CH 2 O-phenylEtMeMeMe
623-F-4-HCF 2 CF 2 CH 2 O-phenylEtMeMeMe
634-F-3-HCF 2 CF 2 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
643-F-4-HCF 2 CF 2 CH 2 O-phenyl—(CH 2 ) 5 —MeMe
653-CF 3 CFHCF 2 CH 2 O-phenylEtMeMeMe
663-HCF 2 CF 2 CF 2 CF 2 CH 2 O-phenylEtMeMeMe
674-HCF 2 CF 2 CF 2 CF 2 CH 2 O-phenylEtMeMeMe
685-HCF 2 CF 2 O-2-pyridylEtMeMeMe
695-HCF 2 O-2-pyridylEtMeMeMe
705-CF 3 CH 2 O-2-pyridylEtMeMeMe
715-HCF 2 CF 2 CH 2 O-2-pyridylEtMeMeMe
725-HCF 2 CF 2 O-2-pyridyl—(CH 2 ) 5 —MeMe
735-HCF 2 O-2-pyridyl—(CH 2 ) 5 —MeMe
745-CF 3 CH 2 O-2-pyridyl—(CH 2 ) 5 —MeMe
755-HCF 2 CF 2 CH 2 O-2-pyridyl—(CH 2 ) 5 —MeMe
762-HCF 2 CF 2 O-5-pyrimidylEtMeMeMe
772-HCF 2 O-5-pyrimidylEtMeMeMe
785-HCF 2 CF 2 O-2-pyrazylEtMeMeMe
795-HCF 2 O-2-pyrazylEtMeMeMe
805-CF 3 CH 2 O-2-pyrazylEtMeMeMe
816-HCF 2 CF 2 O-3-pyridazylEtMeMeMe
826-HCF 2 O-3-pyridazylEtMeMeMe
836-CF 3 CH 2 O-3-pyridazylEtMeMeMe
843-cyclohexyloxy-phenylEtMeMeMe
853-cyclohexyloxy-phenyl—(CH 2 ) 5 —MeMe
863-cyclopentoxy-phenylEtMeMeMe
873-cyclopentoxy-phenyl—(CH 2 ) 5 —MeMe
884-cyclohexyloxy-phenylEtMeMeMe
894-cyclohexyloxy-phenyl—(CH 2 ) 5 —MeMe
904-cyclopentoxy-phenylEtMeMeMe
914-cyclopentoxy-phenyl—(CH 2 ) 5 —MeMe
923-cyclopropylmethoxy-EtMeMeMe
phenyl
933-cyclopropylmethoxy-—(CH 2 ) 5 —MeMe
phenyl
944-cyclopropylmethoxy-EtMeMeMe
phenyl
954-cyclopropylmethoxy-—(CH 2 ) 5 —MeMe
phenyl
964-Cl-3-(cyclopropyl-EtMeMeMe
methoxy)-phenyl
974-F-3-(cyclopropyl-EtMeMeMe
methoxy)-phenyl
983-cyclohexylmethoxy-EtMeMeMe
phenyl
995-cyclopentoxy-2-EtMeMeMe
pyridyl
1005-cyclopropylmethoxy-2-EtMeMeMe
pyridyl
1012-cyclopropylmethoxy-5-EtMeMeMe
pyrimidyl
1023-HCF 2 CF 2 O-phenylEtMeMeH
1033-HCF 2 CF 2 O-phenylEtMeHMe
1043-HCF 2 CF 2 O-phenylEtMeMeCl
1053-HCF 2 CF 2 O-phenylEtMeClCl
1063-HCF 2 CF 2 O-phenylEtMeMeMeO
1073-HCF 2 CF 2 S-phenylEtMeMeMe
TABLE 3
N.M +1 H—NMR
34141.19 (t, 3H); 2.20 (s, 3H); 2.28 (s, 3H); 2.98 (s, 3H);
3.37 (bq, 2H); 5.85 (tt, 1H); 6.72 (bs, 1H); 6.82
(bs, 1H); 7.05-7.35 (c, 4H); 7.50 (bs, 1H)
44261.35-1.80 (c, 4H); 2.20 (s, 3H); 2.28 (s, 3H); 3.30-
3.50 (m, 4H); 5.85 (tt, 1H); 6.72 (bs, 1H); 6.82
(bs, 1H); 6.85-7.35 (c, 4H); 7.50 (bs, 1H)
54401.35-1.80 (c, 6H); 2.20 (s, 3H); 2.28 (s, 3H); 3.30-
3.50 (m, 4H); 5.85 (tt, 1H); 6.72 (bs, 1H); 6.82
(bs, 1H); 6.85-7.35 (c, 4H); 7.50 (bs, 1H)
64422.20 (s, 3H); 2.28 (s, 3H); 3.30-3.50 (m, 4H); 3.65-
3.85 (m, 4H); 5.85 (tt, 1H); 6.72 (bs, 1H); 6.82
(bs, 1H); 6.85-7.35 (c, 4H); 7.50 (bs, 1H)
74402.20 (s, 3H); 2.28 (s, 3H); 3.30-3.50 (m, 4H); 3.65-
3.85 (m, 4H); 5.85 (tt, 1H); 6.72 (bs, 1H); 6.82
(bs, 1 H); 7.05-7.35 (c, 4 H); 7.50 (bs, 1 H)
83641.19 (t, 3H); 2.20 s, 3H); 2.28 (s, 3H); 2.97 (s, 3H);
3.35 (bq, 2H); 6.65 (t, 1H); 6.70 (bs, 1H); 6.80 (bs,
1H); 7.05-7.35 (c, 4H); 7.50 (bs, 1H)
103901.35-1.80 (c, 6H); 2.20 (s, 3H); 2.28 (s, 3H); 3.30-
3.50 (m, 4H); 6.65 (t, 1H); 6.70 (bs, 1H); 6.80 (bs,
1H); 6.85-7.35 (c, 4H); 7.50 (bs, 1H)
133901.35-1.80 (c, 6H); 2.20 (s, 3H); 2.28 (s, 3H); 3.30-
3.50 (m, 4H); 6.65 (t, 1H); 6.70 (bs, 1H); 6.80 (bs,
1H); 7.05-7.35 (c, 4H); 7.50 (bs, 1H)
153961.19 (t, 3H); 2.20 (s, 3H); 2.28 (s, 3H); 2.97 (s, 3H);
3.35 (bq, 2H); 4.25 (q, 2H); 6.72 (bs, 1H); 6.82
(bs, 1H); 6.85-7.35 (c, 4H); 7.50 (bs, 1H)
194281.19 (t, 3H); 2.20 (s, 3H); 2.28 (s, 3H); 2.97 (s, 3H);
3.35 (bq, 2H); 4.25 (q, 2H); 5.85 (tt, 1H); 6.72 (bs,
1H); 6.82 (bs, 1H); 6.85-7.35 (c, 4H); 7.50 (bs, 1H)
234461.19 (t, 3H); 2.20 (s, 3H); 2.28 (s, 3H); 2.97 (s, 3H);
3.35 (bq, 2H); 4.25 (q, 2H); 6.72 (bs, 1H); 6.82
(bs, 1H); 6.85-7.35 (c, 4H); 7.50 (bs, 1H)
274481.19 (t, 3H); 2.20 (s, 3H); 2.28 (s, 3H); 2.98 (s, 3H);
3.37 (bq, 2H); 5.85 (tt, 1H); 6.72 (bs, 1H); 6.82
(bs, 1H); 7.0-7.35 (c, 3H); 7.50 (bs, 1H)
304281.19 (t, 3H); 2.20 (s, 3H); 2.28 (s, 3H); 2.50 (s, 3H);
2.98 (s, 3H); 3.37 (bq, 2H); 5.85 (tt, 1H); 6.72 (bs,
1H); 6.82 (bs, 1H); 6.95-7.35 (c, 3H); 7.50 (bs, 1H)
314821.19 (t, 3H); 2.20 (s, 3H); 2.28 (s, 3H); 2.98 (s, 3H);
3.37 (bq, 2H); 5.85 (tt, 1H); 6.72 (bs, 1H); 6.82
(bs, 1H); 6.90-7.40 (c, 3H); 7.50 (bs, 1H)
324741.35-1.80 (c, 6H); 2.20 (s, 3H); 2.28 (s, 3H); 3.30-
3.50 (m, 4H); 6.65 (t, 1H); 6.70 (bs, 1H); 6.80 (bs,
1H); 6.95-7.35 (c, 3H); 7.50 (bs,1H)
374321.19 (t, 3H); 2.20 (s, 3H); 2.28 (s, 3H); 2.98 (s, 3H);
3.37 (bq, 2H); 5.85 (tt, 1H); 6.72 (bs, 1H); 6.82
(bs, 1H); 7.0-7.35 (c, 3H); 7.50 (bs, 1H)
384321.19 (t, 3H); 2.20 (s, 3H); 2.28 (s, 3H); 2.98 (s, 3H);
3.37 (bq, 2H); 5.85 (tt, 1H); 6.72 (bs, 1H); 6.82
(bs, 1H); 7.0-7.35 (c, 3H); 7.50 (bs, 1H)
394581.35-1.80 (c, 6H); 2.20 (s, 3H); 2.28 (s, 3H); 3.30-
3.50 (m, 4H); 5.85 (tt, 1H); 6.72 (bs, 1H); 6.82
(bs, 1H); 7.0-7.35 (c, 3H); 7.50 (bs, 1H)
404581.35-1.80 (c, 6H); 2.20 (s, 3H); 2.28 (s, 3H); 3.30-
3.50 (m,4H); 5.85 (tt, 1H); 6.72 (bs, 1H); 6.82
(bs, 1H); 7.0-7.35 (c, 3H); 7.50 (bs, 1H)
413981.19 (t, 3H); 2.20 (s, 3H); 2.28 (s, 3H); 2.98 (s, 3H);
3.37 (bq, 2H); 6.65 (tt, 1H); 6.72 (bs, 1H); 6.82
(bs, 1H); 7.0-7.35 (c, 3H); 7.50 (bs, 1H)
423981.19 (t, 3H); 2.20 (s, 3H); 2.28 (s, 3H); 2.98 (s, 3H);
3.37 (bq, 2H); 6.65 (tt, 1H); 6.72 (bs, 1H); 6.82
(bs, 1H); 7.0-7.35 (c, 3H); 7.50 (bs, 1H)
434241.35-1.80 (c, 6H); 2.20 (s, 3H); 2.28 (s, 3H); 3.30-
3.50 (m, 4H); 6.65 (t, 1H); 6.70 (bs, 1H); 6.80 (bs,
1H); 6.95-7.35 (c, 3H); 7.50 (bs, 1H)
453821.19 (t, 3H); 2.20 (s, 3H); 2.28 (s, 3H); 2.98 (s, 3H);
3.37 (bq, 2H); 6.65 (t, 1H); 6.72 (bs, 1H); 6.82 (bs,
1H); 7.0-7.35 (c, 3H); 7.50 (bs, 1H)
474081.35-1.80 (c, 6H); 2.20 (s, 3H); 2.28 (s, 3H); 3.30-
3.50 (m, 4H); 6.60 (tt, 1H); 6.72 (bs, 1H); 6.82
(bs, 1H); 7.0-7.35 (c, 3H); 7.50 (bs, 1H)
494301.19 (t, 3H); 2.20 (s, 3H); 2.28 (s, 3H); 2.97 (s, 3H);
3.35 (bq, 2H); 4.25 (q, 2H); 6.72 (bs, 1H); 6.82
(bs, 1H); 6.85-7.35 (c, 3H); 7.50 (bs, 1H)
534141.19 (t, 3H); 2.20 (s, 3H); 2.28 (s, 3H); 2.97 (s, 3H);
3.35 (bq, 2H); 4.25 (q, 2H); 6.72 (bs, 1H); 6.82
(bs, 1H); 6.90-7.40 (c, 3H); 7.50 (bs, 1H)
574621.19 (t, 3H); 2.20 (s, 3H); 2.28 (s, 3H); 2.97 (s, 3H);
3.35 (bq, 2H); 4.25 (q, 2H); 5.85 (tt, 1H); 6.72 (bs,
1H); 6.82 (bs, 1H); 6.90-7.35 (c, 3H); 7.50 (bs, 1H)
614461.19 (t, 3H); 2.20 (s, 3H); 2.28 (s, 3H); 2.97 (s, 3H);
3.35 (bq, 2H); 4.25 (q, 2H); 5.85 (tt, 1H); 6.72 (bs,
1H); 6.82 (bs, 1H); 6.95-7.35 (c, 3H); 7.50 (bs, 1H)
684151.19 (t, 3H); 2.20 (s, 3H); 2.28 (s, 3H); 2.98 (s, 3H);
3.37 (bq, 2H); 5.85 (tt, 1H); 6.72 (bs, 1H); 6.82
(bs, 1H); 7.10-7.90 (c, 4H)
863821.19 (t, 3H); 1.50-2.0 (m, 8H); 2.20 (s, 3H); 2.28
(s, 3H); 2.98 (s, 3H); 3.37 (bq, 2H); 4.80 (m, 1H); 6.72
(bs, 1H); 6.83 (bs, 1H); 6.9-7.35 (c, 4H); 7.50 (bs, 1H)
923680.35 (m, 2H); 0.65 (m, 2H); 1.19 (t, 3H); 1.30 (m, 1H);
2.20 (s, 3H); 2.28 (s, 3H); 2.98 (s, 3H); 3.37 (bq, 2H);
4.90 (s, 2H); 6.72 (bs, 1H); 6.82 (bs, 1H); 6.9-7.35
(c, 4H); 7.50 (bs, 1H)
TABLE 4
Activity P5Phytotoxicity
CompoundppmTNT% N.F.
N. 11251001000
301001000
N. 21251001000
301001000
N. 151251001000
301001000
N. 191251001000
301001000
N. 231251001000
301001000
CR-11251009025
30907615
CR-212595800
3078650
CR-31251009635
30958520
CR-4125959030
30757015
CR-5125908030
30706520
TABLE 5
Activity P5Phytotoxicity %
CompoundppmTNTN.F.
11251001000
301001000
21251001000
301001000
151251001000
301001000
191251001000
301001000
231251001000
301001000
CR-11251009026
30807014
CR-212595900
3068600
CR-312510010033
30958521
CR-4125908530
30706520
CR-5125858025
30656015
4 of 13 part labels are ours — the grant heads the rest

Claims as granted

15 claims

Log in to read the claims of this application.

Log in to unlock

Classifications

21 codes
IPC · International Patent Classification
Section A — Human necessities
  • A01N43/58
  • A01N43/40
  • A01N37/52
  • A01N43/36
  • A01N43/84
  • A01N43/54
  • A01N43/56
  • A01N43/60
Section C — Chemistry; metallurgy
  • C07D231/44
  • C07D237/18
  • C07C323/41
  • C07D295/195
  • C07D295/13
  • C07D241/18
  • C07D213/70
  • C07D239/56
USPC · US Patent Classification
504/101514/252514/247504/358514/238

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this application are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoomJul 2011Jan 2012Jul 2012Jan 2013Jul 2013Jan 2014Jul 2014Jan 2015Jul 2015USPTOApplicantNon-final rejectionResponse after non-final
USPTOApplicanthover for detail · click to open
Pendency
3.8 y
1,377 days filing → grant
Office actions
1
non-final + final
Responses
2
no RCE
Interviews
1
examiner interview summaries
Examiner
Ali Soroush
art unit 1617 · TC 1600
Citations: 6 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Documents

Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.

Log in to unlock

Chain of title

⤢ drag to zoom2014201620182020202220242026202820302032Owner 1
Titlehover for detail · click to open

See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.

Log in to unlock